SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $54.7K invested in Scinai Immunotherapeutics in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.35K
2
+$278
3
+$45

Top Sellers

1
-$63.2K
2
-$20.8K
3
-$6.31K
4
Millennium Management
Millennium Management
New York
-$5.48K
5
Morgan Stanley
Morgan Stanley
New York
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$49.6K
2
$3.24K
3
$709
4
$586
5
$278
6
$117
7
$89
8
$59
9
$14
10
–
11
–
12
–
13
–